1Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, United States of America
2Department of Neurology, University of Texas Southwestern Medical Center, Dallas, United States of America
3Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States of America
4F.M. Kirby Research Center, Kennedy Krieger Research Institute, Baltimore, United States of America
5Department of Radiology, Johns Hopkins University, Baltimore, United States of America
Presenting Author: Anke Henning
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Pondrelli, F., et al., Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis. Orphanet Journal of Rare Diseases, 2021. 16(1): p. 362. doi: 10.1186/s13023-021-01989-w [doi]
2. Sullivan, M.A., et al. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan. International Journal of Molecular Sciences, 2017. 18, doi: 10.3390/ijms18081743. [doi]
3. Raththagala, M., et al., Structural Mechanism of Laforin Function in Glycogen Dephosphorylation and Lafora Disease. Molecular Cell, 2015. 57(2): p. 261-272. doi: 10.1016/j.molcel.2014.11.020 [doi]
4. Gentry, M.S., et al., Lafora disease offers a unique window into neuronal glycogen metabolism. Journal of Biological Chemistry, 2018. 293(19): p. 7117-7125. doi: 10.1074/jbc.R117.803064 [doi]
5. Ahonen, S., et al., Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease. Brain, 2021. 144(10): p. 2985-2993. doi: 10.1093/brain/awab194 [doi]
6. Donohue, K.J., et al., Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model. Neurotherapeutics, 2023. 20(6): p. 1808-1819. doi: 10.1007/s13311-023-01434-9 [doi]
7. Xu, X., et al., MRI of GlycoNOE in the human liver using GraspNOE-Dixon. Magnetic Resonance in Medicine, 2025. 93(2): p. 507-518. doi: 10.1002/mrm.30270 [doi]
8. Bie, C., et al., In vivo imaging of glycogen in human muscle. Nature Communications, 2024. 15(1): p. 10826. doi: 10.1038/s41467-024-55132-x [doi]
9. Zhou, Y., et al., Magnetic resonance imaging of glycogen using its magnetic coupling with water. Proceedings of the National Academy of Sciences, 2020. 117(6): p. 3144-3149. doi: 10.1073/pnas.1909921117 [doi]
10. Keupp, J., et al. Parallel RF Transmission based MRI Technique for Highly Sensitive Detection of Amide Proton Transfer in the Human Brain at 3T. in The International Society for Magnetic Resonance in Medicine. 2011. Montréal, QC, Canada.
11. Kim, M., et al., Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med, 2009. 61(6): p. 1441-50. doi: 10.1002/mrm.21873 [doi]
12. Zaiß, M., B. Schmitt, and P. Bachert, Quantitative separation of CEST effect from magnetization transfer and spillover effects by Lorentzian-line-fit analysis of z-spectra. Journal of Magnetic Resonance, 2011. 211(2): p. 149-155. doi: 10.1016/j.jmr.2011.05.001 [doi]
13. Kong, J., et al., Brain Glycogen Decreases with Increased Periods of Wakefulness: Implications for Homeostatic Drive to Sleep. The Journal of Neuroscience, 2002. 22(13): p. 5581. doi: 10.1523/JNEUROSCI.22-13-05581.2002 [doi]